NOT-DA-20-057: Notice of Change to Key Dates for PAR-19-258, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice of Change to Key Dates for PAR-19-258, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-20-057

Key Dates

Release Date:

Related Announcements

PAR-19-258

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform interested applicants of a change to the key dates for PAR-19-258, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)".

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Date(s)	July 22, 2019; July 22, 2020; July 22, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
AIDS Application Due Date(s)	September 7, 2019; September 7, 2020; and September 7, 2021 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Scientific Merit Review	October/November 2019; October/November 2020; and October/November 2021
Advisory Council Review	January 2020; January 2021; and January 2022
Earliest Start Date	April 2020
Expiration Date	September 8, 2021

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Date(s)	July 22, 2019; August 13, 2020, August 10, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
AIDS Application Due Date(s)	September 7, 2019; August 13, 2020, August 10, 2021 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Scientific Merit Review	October/November 2019; October/November 2020; and October/November 2021
Advisory Council Review	January 2020; January 2021; and January 2022
Earliest Start Date	April 2020
Expiration Date	August 11, 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Belinda E. Sims, Ph.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1533
Email: [email protected]

Guifang Lao, Ph.D.
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6173
Email: [email protected]

Yu (Woody) Lin, M.D., Ph.D.
Integrative Neuroscience Branch
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301 435-1318
Email: [email protected]

Beth Babecki, M.A.
Coordinator, Training Hub
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0899
Email: [email protected]

Flair Lindsey
Office of Research Training
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5783
Email: [email protected]